News

With no exemptions for medical devices from Trump’s double-digit tariffs, pacemakers, insulin pumps and hearing aids could ...
Hundreds of lawsuits allege that insulin manufacturers and pharmacy benefit managers colluded to raise prices. The ...
Like tens of thousands of Massachusetts residents, community college professor Carolyn McGrath has been paying for medicine ...
Insulin: In 2019, employer plan participants who used insulin spent an average of $82 per month out-of-pocket on their ...
The North Texas hospital system joins over 400 other entities and a dozen state attorneys general suing over alleged ...
Insulin device maker Insulet Corporation (NASDAQ ... The analyst maintains the Outperform rating. Price Action: PODD stock is down 7.35% at $185.11 at last check on Friday.
Mizuho initiated coverage of Tandem Diabetes (TNDM) with a Neutral rating and $20 price target The firm’s neutral stance reflects both the ...